Form 4: Charles River Laboratories Executive Transfers Shares to Revocable Trust
SEC Form 4 Filing
William D. Barbo, Corporate Executive VP & CCO of Charles River Laboratories, transferred 965 shares of common stock to a revocable trust on November 7, 2024.
Summary
- On November 7, 2024, William D. Barbo, Corporate Executive VP & CCO of Charles River Laboratories International, Inc., transferred 965 shares of common stock to the William D. Barbo Revocable Trust.
- This transaction was an exempt transfer pursuant to Rule 16a-13.
- Following the transaction, Mr. Barbo directly owns 2,468 shares and indirectly owns 23,337 shares through a trust.
Sentiment
Score: 7
Explanation: The document reflects a neutral transaction (transfer to a trust) with no apparent positive or negative implications for the company's financial health or future prospects.
Industry Context
This is a routine disclosure related to executive stock ownership and does not suggest any specific trend in the broader industry.
Stakeholder Impact
- The transaction has minimal impact on stakeholders as it is a transfer of shares for estate planning purposes and does not change the overall ownership structure significantly.
Key Dates
| Date | Description |
|---|---|
| 11/07/2024 | Date of the share transfer to the William D. Barbo Revocable Trust |
| 11/08/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.